Liver disease contraception — DFSRH MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Offer a 52 mg levonorgestrel IUD after eligibility assessment
The best answer is “Offer a 52 mg levonorgestrel IUD after eligibility assessment”. UKMEC assessment depends on the severity and type of liver disease rather than a blanket ban on hormonal methods. A 52 mg LNG-IUD is highly effective and can reduce menstrual blood loss. A copper IUD may worsen bleeding, combined methods do not bypass hepatic considerations, and stable compensated disease does not justify withholding contraception.
Reference: CoSRH, UK Medical Eligibility Criteria for Contraceptive Use 2025: https://www.cosrh.org/Common/Uploaded%20files/documents/UKMEC_2025.pdf